At meeting held on 23 July 2021
The Board of Marksans Pharma at its meeting held 23 July 2021 has approved allotment of 10 lakh convertible warrants on preferential basis to Mark Saldanha (Promoter of the Company) at a price of Rs 74.00 per warrant and 4,93,24,324 convertible warrants on preferential basis to OrbiMed Asia IVMauritius FVCI at a price of Rs 74.00 per share.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content